Log in to search using one of your social media accounts:

 

Medical Extrusion Technologies loses trademark bid

A U.S. trademark board last week shot down a bid by Medical Extrusion Technologies to trademark its name, ruling that the name is not distinct enough to trademark. MET applied to trademark its name for “polyurethanes in the form of sheets, films, pellets, granules, and tubes for use in the manufacture of medical devices, medical diagnostic devices, artificial vascular grafts, stents, pacemaker leads, artificial heart pump diaphragms, catheters, drug delivery devices, orthopedic and spinal implants, blood glucose monitors, and blood gas analyzers.” Get the full story at our sister site, Medical Design &Outsourcing. The post Medical Extrusion Technologies loses trademark bid appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Legal News apollomedicalextrusiontechnologies U.S. Patent & Trademark Office (USPTO) Source Type: news

Related Links:

Authors: Matsumoto K, Yamasaki N, Tsuchiya T, Miyazaki T, Kamohara R, Hatachi G, Tanigawa K, Eishi K, Nagayasu T Abstract The number of patients who need cardiac support with a left ventricular assist device (LVAD) has increased over the last decade. However, the number of reports of organ retrieval from donors with an LVAD is still small. Successful lung retrieval for single lung transplantation was performed from a donor on LVAD support. This required special care not to injure the heart, great vessels, and the device, particularly the outflow conduit, because of significant conglutination around the device. A ri...
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
Authors: Koulova A, Gass AL, Patibandla S, Gupta CA, Aronow WS, Lanier GM Abstract Pulmonary hypertension in left heart disease (PH-LHD) commonly complicates prolonged heart failure (HF). When advanced, the PH becomes fixed or out of proportion and is associated with increased morbidity and mortality in patients undergoing orthotopic heart transplant (OHT). To date, the only recommended treatment of out of proportion PH is the treatment of the underlying HF by reducing the pulmonary capillary wedge pressure (PCWP) with medications and often along with use of mechanical circulatory support. Medical therapies typical...
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
By SUHAS GONDI As the Senate debated the fate of the Affordable Care Act (ACA) in Washington this past summer, healthcare was front and center in newspapers and conversations around the country. While insurance coverage and the affordability of care certainly warrant the level of nationwide attention they received, they comprise only one dimension of the systemic deficits in US healthcare: access to care. Meanwhile, the pressing need to reform our broken delivery and payment structures and address the more than $1 trillion of waste in our system was being overlooked by lawmakers in DC. Luckily, on the other side of the co...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Tech Source Type: blogs
CONCLUSION: The TAH provides an alternative with low incidence of neurologic events in extremely fragile and complex patients waiting for heart transplantation. Complex and unusual anatomic conditions explained the current use of TAH. PMID: 28930049 [PubMed - as supplied by publisher]
Source: Canadian Journal of Surgery - Category: Surgery Authors: Tags: Can J Surg Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Conclusions: The results demonstrate that it is possible to classify resuscitation cardiac rhythms automatically, but the accuracy for the organized rhythms (PEA and PR) is low. Significance: We have made an important step toward making classification of resuscitation rhythms more ef- icient in the sense of minimal feedback from human experts.
Source: IEEE Transactions on Biomedical Engineering - Category: Biomedical Engineering Source Type: research
AbstractPurpose of ReviewHeart failure is increasing in prevalence with a lack of recently developed therapies that produce major beneficial effects on its associated mortality. MicroRNAs are small non-coding RNA molecules that regulate gene expression, are differentially regulated in heart failure, and are found in the circulation serving as a biomarker of heart failure.Recent FindingsData suggests that microRNAs may be used to detect allograft rejection in cardiac transplantation and may predict the degree of myocardial recovery in patients with a left ventricular assist device or treated with beta-blocker therapy. Given...
Source: Current Heart Failure Reports - Category: Cardiology Source Type: research
Publication date: October 2017 Source:Canadian Journal of Cardiology, Volume 33, Issue 10, Supplement Author(s): E. Jean-St-Michel, J. Meza, J. Maguire, J. Coles, B. McCrindle
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Cardiology | Heart | Heart Transplant | Legislation | Medical Devices | Orthopaedics